Cargando…
Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study
BACKGROUND: People living with HIV might have a poor or delayed response to vaccines, mainly when CD4 cell counts are low, and data concerning COVID-19 vaccines in this population are scarce. This prospective cohort study assessed the safety and immunogenicity of the inactivated SARS-CoV-2 vaccine C...
Autores principales: | Netto, Lucas C, Ibrahim, Karim Y, Picone, Camila M, Alves, Ana Paula P S, Aniceto, Eliane V, Santiago, Mariana R, Parmejani, Patrícia S S, Aikawa, Nadia E, Medeiros-Ribeiro, Ana C, Pasoto, Sandra G, Yuki, Emily F N, Saad, Carla G S, Pedrosa, Tatiana, Lara, Amanda N, Ceneviva, Carina, Bonfa, Eloisa, Kallas, Esper G, Avelino-Silva, Vivian I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942475/ https://www.ncbi.nlm.nih.gov/pubmed/35338835 http://dx.doi.org/10.1016/S2352-3018(22)00033-9 |
Ejemplares similares
-
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients
por: Silva, Clovis A., et al.
Publicado: (2022) -
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study
por: Aikawa, Nadia E, et al.
Publicado: (2022) -
Boosting immunity after CoronaVac
por: Sester, Martina, et al.
Publicado: (2022) -
CoronaVac: more data for regulators and policy makers
por: Ramasamy, Maheshi N, et al.
Publicado: (2021) -
Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial
por: Samoud, Samar, et al.
Publicado: (2023)